| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |